The Genomics Research and Innovation Network: creating an interoperable, federated, genomics learning system.
Mandl, KD; Glauser, T; Krantz, ID; Avillach, P; Bartels, A; Beggs, AH; Biswas, S; Bourgeois, FT; Corsmo, J; Dauber, A; et al.
Genetics in Medicine.
2020;
22:371-380.
Development of information sharing in language neocortex in childhood-onset drug-resistant epilepsy.
Arya, R; Ervin, B; Wilson, JA; Byars, AW; Rozhkov, L; Buroker, J; Horn, PS; Scholle, C; Fujiwara, H; Greiner, HM; et al.
Epilepsia.
2019;
60:393-405.
Pretreatment behavior and subsequent medication effects in childhood absence epilepsy.
Shinnar, RC; Shinnar, S; Cnaan, A; Clark, P; Dlugos, D; Hirtz, DG; Hu, F; Liu, C; Masur, D; Weiss, EF; et al.
Neurology.
2017;
89:1698-1706.
Pretreatment seizure semiology in childhood absence epilepsy.
Kessler, SK; Shinnar, S; Cnaan, A; Dlugos, D; Conry, J; Hirtz, DG; Hu, F; Liu, C; Mizrahi, EM; Moshe, SL; et al.
Neurology.
2017;
89:673-679.
Pharmacogenetics of Antiepileptic Drug Efficacy in Childhood Absence Epilepsy.
Glauser, TA; Holland, K; O'Brien, VP; Keddache, M; Martin, LJ; Clark, PO; Cnaan, A; Dlugos, D; Hirtz, DG; Shinnar, S; et al.
Annals of Neurology.
2017;
81:444-453.
Second monotherapy in childhood absence epilepsy.
Cnaan, A; Shinnar, S; Arya, R; Adamson, PC; Clark, PO; Dlugos, D; Hirtz, DG; Masur, D; Glauser, TA; Study, CA E.
Neurology.
2017;
88:182-190.
Long-term outcomes of generalized tonic-clonic seizures in a childhood absence epilepsy trial.
Shinnar, S; Cnaan, A; Hu, F; Clark, P; Dlugos, D; Hirtz, DG; Masur, D; Mizrahi, EM; Moshe, SL; Glauser, TA; et al.
Neurology.
2015;
85:1108-1114.
Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: Initial monotherapy outcomes at 12 months.
Glauser, TA; Cnaan, A; Shinnar, S; Hirtz, DG; Dlugos, D; Masur, D; Clark, PO; Adamson, PC; Study, CA E.
Epilepsia.
2013;
54:141-155.
Ethosuximide, Valproic Acid, and Lamotrigine in Childhood Absence Epilepsy.
Glauser, TA; Cnaan, A; Shinnar, S; Hirtz, DG; Dlugos, D; Masur, D; Clark, PO; Capparelli, EV; Adamson, PC; Study, CA E.
The New England journal of medicine.
2010;
362:790-799.
First-line medication dosing in pediatric refractory status epilepticus.
Vasquez, A; Gaínza-Lein, M; Abend, NS; Amengual-Gual, M; Anderson, A; Arya, R; Brenton, JN; Carpenter, JL; Chapman, K; Clark, J; et al.
Neurology.
2020;
95:e2683-e2696.